書誌事項
- タイトル別名
-
- Combined Therapy after Superselective Arterial Docetaxel (taxotere) Infusion to Treat Advanced Maxillary Sinus Cancer
この論文をさがす
抄録
Therapy combining in treating maxillary sinus cancer, surgery, chemotherapy, and radiation is a primary modality. While chemotherapy administered through the superficial temporal artery is conventionally used, we have worked since 2003 to assess the efficacy of combined therapy after superselective arterial docetaxel (taxotere) infusion for treating maxillary sinus cancer. Treatment consisted of preoperative radiation of 40Gy. The regimen, used to date in 3 men and 2 women, all with advanced maxillary sinus cancer, included planned surgery about two weeks after radiation therapy. Based on T classification, 1997 UICC three were in stage T3 and two in stage T4.<br>Malignancies were three squamous cell carcinomas, one small cell carcinoma and undifferentiated carcinoma. As this therapy, the effectiveness was proved for histopatholory. At present, all five subjects have survived, indicating that combined superselective arterial docetaxel (taxotere) therapy is very effective against maxillary sinus cancer.
収録刊行物
-
- 日本鼻科学会会誌
-
日本鼻科学会会誌 48 (2), 123-127, 2009
日本鼻科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679713455616
-
- NII論文ID
- 130004545996
- 10025380367
-
- NII書誌ID
- AN00062865
-
- ISSN
- 18837077
- 09109153
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可